Company / Current Assets per Share
Edesa Biotech, Inc. Current Assets per Share History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.26
FY2021
5-year range
$0.67 / $7.09
FY2017-FY2021
Trend
+16.4%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 7 years, ranging from $0.24 in FY2014 to $7.09 in FY2018.
Based on SEC 10-K filings.
1.26 in FY2021 with a 5-year CAGR of -3.7%.
Declined from $7.09 to $1.26 over the past 3 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -43.8%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, current assets per share increased 16.4% year-over-year.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $1.26 | +16.4% |
| FY2020 | $1.08 | -84.8% |
| FY2018 | $7.09 | +963.4% |
| FY2017 | $0.67 | -56.0% |
| FY2016 | $1.52 | -15.7% |
| FY2015 | $1.80 | +640.3% |
| FY2014 | $0.24 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026